Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MiRNA Expression Profile as a Potential Biomarker for Idiopathic Congenital Talipes Equinovarus: An Exploratory Study.

Orthopedic reviews·2026
Same author

MicroRNA Profiling in Chronic Limb-Threatening Ischemia Their Role in Arteriogenesis.

The International journal of angiology : official publication of the International College of Angiology, Inc·2025
Same author

Research trends in microRNA profiling as a biomarker for lung adenocarcinoma via liquid biopsy: A bibliometric analysis.

Narra J·2025
Same author

Endothelial-Derived Microparticles Associate with Hospital Major Adverse Cardiovascular Events but not with Long-Term Adverse Events in Acute Myocardial Infarction.

The International journal of angiology : official publication of the International College of Angiology, Inc·2024
Same author

Correlation between circulating fibrosis biomarkers with left atrial function and left atrial volume index in rheumatic mitral stenosis.

Narra J·2024
Same author

Recent progress in the roles of microRNAs in pulmonary arterial hypertension associated with congenital heart disease.

Narra J·2024

Related Experiment Video

Updated: Jun 2, 2025

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia
09:11

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia

Published on: January 23, 2009

11.7K

HUVECs-derived exosomes increase neovascularization and decrease limb necrosis in hindlimb ischemia.

Muhamad T Ismail1, Dyah W Anggrahini1, Sofia M Haryana2

  • 1Department of Cardiology and Vascular Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Narra J
|January 16, 2025
PubMed
Summary
This summary is machine-generated.

Human umbilical vein endothelial cells (HUVECs)-derived exosomes significantly reduced amputation and necrosis in a hindlimb ischemia model. These exosomes promote neovascularization, offering a promising therapeutic strategy for peripheral arterial disease.

Keywords:
Exosomeamputationchronic limb-threatening ischemiahindlimb ischemianeovascularization

More Related Videos

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
07:48

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia

Published on: June 8, 2019

8.7K
A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision
05:47

A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision

Published on: May 13, 2021

3.8K

Related Experiment Videos

Last Updated: Jun 2, 2025

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia
09:11

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia

Published on: January 23, 2009

11.7K
Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
07:48

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia

Published on: June 8, 2019

8.7K
A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision
05:47

A Modified Surgical Model of Hind Limb Ischemia in ApoE-/- Mice using a Miniature Incision

Published on: May 13, 2021

3.8K

Area of Science:

  • Regenerative Medicine
  • Vascular Biology
  • Biotechnology

Background:

  • Chronic limb-threatening ischemia (CLTI) is a severe form of peripheral arterial disease (PAD) with high mortality and amputation rates.
  • Current revascularization treatments are insufficient for many CLTI patients, necessitating novel therapeutic approaches.
  • Exosomes derived from human umbilical vein endothelial cells (HUVECs) are being explored for their therapeutic potential.

Purpose of the Study:

  • To investigate the efficacy of HUVECs-derived exosomes in promoting neovascularization and reducing necrosis in a mouse hindlimb ischemia model.
  • To elucidate the underlying biological mechanisms of exosome-mediated therapeutic effects.

Main Methods:

  • An in vivo experimental study using a post-test-only control group design in BALB/c mice with unilateral double ligation of the hindlimb.
  • Groups included HUVECs-derived exosomes, conditioned media, phosphate-buffered saline (PBS), and a sham-operated control.
  • Assessment of capillary density, arteriole lumen diameter, clinical and histopathological necrosis, microRNA profiling, in silico analysis, and VEGF mRNA expression.

Main Results:

  • The exosome group showed no amputations, compared to 43% in the PBS group.
  • Significantly increased capillary density and arteriole lumen diameter were observed in the exosome group versus PBS and sham groups.
  • Reduced clinical and histopathological necrosis scores were noted in the exosome group compared to the PBS group.

Conclusions:

  • HUVECs-derived exosomes effectively improve neovascularization and decrease necrosis in a hindlimb ischemia model.
  • Potential mechanisms involve energy regulation, PI3K/AKT and TGF-β activation, the ubiquitin-proteasome system, and tyrosine kinase receptors.
  • Exosomes represent a promising cell-free therapeutic strategy for managing CLTI and PAD.